2018

CDRD has been selected for a Science Co-op Employer Recognition Award by the University of British Columbia (UBC). In addition, two of CDRD’s employees: David Shin, Data Integrity Manager and Eric Cruz, Associate Scientist in Biologics, have also been selected to receive Supervisor Awards.

On World Diabetes Day, Zucara Therapeutics, a CDRD and MaRS Innovation portfolio company, is raising awareness about hypoglycemia (low blood sugar) that can cause serious complications and even death for people with diabetes.

To exemplify the collaborative spirit and leadership needed to advance the Canadian health and biosciences sector, Canadian life sciences leaders – CDRD, LifeSciences BC, TRIUMF Innovations and BIOTECanada – are hosting an event today to build support and encourage action and agreement that will advance recommendations from The Government of Canada’s Health and Biosciences Economic Strategy Table Report.

Through this new structure, CDRD will be even stronger, and seek to realize our vision of Canadian life sciences leading the world.

Didier is at the forefront of life sciences investment in Canada, working with the Fonds de solidarité FTQ on a mission that is perfectly aligned with CDRD’s, to contribute to Québec’s and Canada’s economic growth by creating jobs through investments in small and medium-sized businesses, helping them scale up to be new life sciences anchor companies.

The award recognizes CDRD’s contributions and impact as Canada’s national life sciences venture, bringing together national and international partners to be a catalyst for Canadian life sciences leading the world; and powering the country’s industry by creating and growing companies of scale while training the scientific business talent needed to drive them to become leading global anchors for Canada.

CDRD and BIOTECanada invite you to a thought-provoking evening to experience the change unfolding in real time.

Sepset Biosciences is developing a novel rapid diagnostic test that will enable healthcare professionals to provide earlier and more targeted treatment of sepsis.